Business Description
Jenburkt Pharmaceuticals Ltd
ISIN : INE354A01013
Compare
Compare
Traded in other countries / regions
524731.India IPO Date
2000-11-27Description
Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 281.47 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 133.9 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 14.96 | |||||
Beneish M-Score | -1.98 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.6 | |||||
3-Year EBITDA Growth Rate | 17.7 | |||||
3-Year EPS without NRI Growth Rate | 17.7 | |||||
3-Year FCF Growth Rate | -31.9 | |||||
3-Year Book Growth Rate | 15.2 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.7 | |||||
9-Day RSI | 48.63 | |||||
14-Day RSI | 53.71 | |||||
6-1 Month Momentum % | 0.93 | |||||
12-1 Month Momentum % | 10.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.7 | |||||
Quick Ratio | 6.18 | |||||
Cash Ratio | 4.52 | |||||
Days Inventory | 103.97 | |||||
Days Sales Outstanding | 44.39 | |||||
Days Payable | 76.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.63 | |||||
Dividend Payout Ratio | 0.24 | |||||
Forward Dividend Yield % | 1.73 | |||||
5-Year Yield-on-Cost % | 1.63 | |||||
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 2.23 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.02 | |||||
Operating Margin % | 21.73 | |||||
Net Margin % | 18.34 | |||||
FCF Margin % | 3.93 | |||||
ROE % | 19.59 | |||||
ROA % | 17.06 | |||||
ROIC % | 28.01 | |||||
ROC (Joel Greenblatt) % | 96.73 | |||||
ROCE % | 25.98 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.85 | |||||
PE Ratio without NRI | 14.85 | |||||
Shiller PE Ratio | 18.65 | |||||
Price-to-Owner-Earnings | 21.9 | |||||
PEG Ratio | 1.6 | |||||
PS Ratio | 2.72 | |||||
PB Ratio | 2.66 | |||||
Price-to-Tangible-Book | 2.67 | |||||
Price-to-Free-Cash-Flow | 69.26 | |||||
Price-to-Operating-Cash-Flow | 47.47 | |||||
EV-to-EBIT | 8.81 | |||||
EV-to-EBITDA | 8.26 | |||||
EV-to-Revenue | 2.2 | |||||
EV-to-FCF | 56.59 | |||||
Price-to-Projected-FCF | 1.63 | |||||
Price-to-DCF (Earnings Based) | 1.02 | |||||
Price-to-DCF (FCF Based) | 7.46 | |||||
Price-to-Median-PS-Value | 1.31 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.53 | |||||
Price-to-Graham-Number | 1.33 | |||||
Price-to-Net-Current-Asset-Value | 4.31 | |||||
Price-to-Net-Cash | 7.17 | |||||
Earnings Yield (Greenblatt) % | 11.36 | |||||
FCF Yield % | 1.44 | |||||
Forward Rate of Return (Yacktman) % | 12.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jenburkt Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1,416.333 | ||
EPS (TTM) (₹) | 58.87 | ||
Beta | 0.94 | ||
Volatility % | 41.06 | ||
14-Day RSI | 53.71 | ||
14-Day ATR (₹) | 30.097699 | ||
20-Day SMA (₹) | 878.8075 | ||
12-1 Month Momentum % | 10.92 | ||
52-Week Range (₹) | 586.9 - 925 | ||
Shares Outstanding (Mil) | 4.41 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jenburkt Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jenburkt Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Jenburkt Pharmaceuticals Ltd Frequently Asked Questions
What is Jenburkt Pharmaceuticals Ltd(BOM:524731)'s stock price today?
The current price of BOM:524731 is ₹874.00. The 52 week high of BOM:524731 is ₹925.00 and 52 week low is ₹586.90.
When is next earnings date of Jenburkt Pharmaceuticals Ltd(BOM:524731)?
The next earnings date of Jenburkt Pharmaceuticals Ltd(BOM:524731) is .
Does Jenburkt Pharmaceuticals Ltd(BOM:524731) pay dividends? If so, how much?
The Dividend Yield %  of Jenburkt Pharmaceuticals Ltd(BOM:524731) is 1.63% (As of Today), Highest Dividend Payout Ratio of Jenburkt Pharmaceuticals Ltd(BOM:524731) was 0.57. The lowest was 0.03. And the median was 0.25. The  Forward Dividend Yield % of Jenburkt Pharmaceuticals Ltd(BOM:524731) is 1.73%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |